Brief: European Medicines Agency (EMA) Validates Henlius And Organon Filing For Perjeta® (Pertuzumab) Biosimilar Candidate HLX11
28/03/2025 12:41
March 28 (Reuters) - Organon & Co OGN.N: EUROPEAN MEDICINES AGENCY (EMA) VALIDATES HENLIUS AND ORGANON FILING FOR PERJETA® (PERTUZUMAB) BIOSIMILAR CANDIDATE HLX11 Source text: ID:nBw2xn1f7a Further company coverage: OGN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary